Abstract
Background Systematic data on the care of people dying with COVID-19 are scarce. We studied the response of and challenges for palliative care services during the COVID-19 pandemic.
Methods We surveyed palliative care and hospice services, contacted via relevant organisations. Multivariable logistic regression identified associations with key challenges. Content analysis explored free text.
Findings 458 services responded; 277 UK, 85 rest of Europe, 95 rest of the world (1 country unreported); 81% cared for patients with suspected or confirmed COVID-19, 77% had staff with suspected or confirmed COVID-19; 48% reported shortages of Personal Protective Equipment (PPE), 40% staff shortages, 24% medicines shortages, 14% shortages of other equipment. Services provided direct care and education in symptom management and communication; 91% changed how they worked. Care often shifted to increased community and hospital care, with fewer admissions to inpatient palliative care units. Factors associated with increased odds of PPE shortages were: charity rather than public management (OR 3·07, 95% CI 1·81-5·20), inpatient palliative care unit rather than other setting (OR 2·34, 95% CI 1·46-3·75). Being outside the UK was associated with lower odds of staff shortages (OR 0·44, 95% CI 0·26-0·76). Staff described increased workload, concerns for their colleagues who were ill, whilst expending time struggling to get essential equipment and medicines, perceiving they were not a front-line service.
Interpretation Across all settings palliative care services were often overwhelmed, yet felt ignored in the COVID-19 response. Palliative care needs better integration with health care systems when planning and responding to future epidemics/pandemics.
Funding MRC grant number MR/V012908/1, Cicely Saunders International and NIHR ARC South London.
Evidence before this study Systematic data on the response of palliative care services during COVID-19 are lacking. A search of PubMed on 27 August 2020 (start date: 01 December 2019) using keywords (palliative care OR end of life care OR hospice) and (COVID-19 OR coronavirus) and (multinational OR international) identified no studies that reported multinational or international data; there were 79 articles, mostly opinion pieces, single centre case studies or reports. A search for systematic reviews about palliative care and hospice services during pandemics of PubMed, with the same time periods and the keywords (palliative care OR end of life care OR hospice) and (COVID-19 OR coronavirus OR SARS-CoV-2) and (systematic review OR meta-analysis), identified one systematic review by Etkind et al, which underpinned this research and shares two senior authors (Higginson, Sleeman). Of 3094 articles identified, 10 studies, all observational, considered the palliative care response in pandemics. Studies were from single units or countries: West Africa, Taiwan, Hong Kong, Singapore, the U.S. (a simulation), and Italy (the only one considering COVID-19). The review concluded hospice and palliative care services are essential in the response to COVID-19 but systematic data are urgently needed to inform how to improve care for those who are likely to die, and/or have severe symptoms.
Added value of this study We found a high response by palliative care services during the COVID-19 pandemic. Services cared for a surge in patients dying from and with severe symptoms due to COVID-19 in three main categories: patients with underlying conditions and/or multimorbid disease not previously known to palliative care (70% of services), patients already known to palliative care services (47% of services), and patients, previously healthy, now dying from COVID-19 (37% of services). More than three quarters of services reported having staff with suspected or confirmed COVID-19. We found high levels of shortages of Personal Protective Equipment (PPE), staff, medicines and other equipment, with different effects according to service management, care settings and world regions. Mitigating these challenges was extremely time consuming, limiting the palliative care response.
Implications of all the available evidence Despite actively supporting dying patients, those with severe symptoms, their families/carers, and supporting other clinicians, palliative care professionals felt ignored by national health systems during the COVID-19 pandemic. Palliative care services need equipment, medicines and adequate staff to contribute fully to the pandemic response. Their crucial role must be better recognised and integrated, including into infection disease management, with improved workforce planning and management, so that patients and families can be better supported.
Competing Interest Statement
Dr. Bajwah, Dr Bradshaw, Dr Oluyase, Prof Preston, Ms Dunleavy, Prof Walshe, report grants from Medical Research Council [MR/V012908/1], during the conduct of the study Dr. Hocaoglu reports grants from Medical Research Council [MR/V012908/1], grants from National Institute for Health Research (NIHR) Applied Research Collaboration, South London, during the conduct of the study. Dr. Sleeman reports grants from Medical Research Council [MR/V012908/1], grants from National Institute for Health Research (NIHR) Applied Research Collaboration, South London, grants from National Institute for Health Research (NIHR) Career Development Fellowship (CDF-2017-10-009), grants from NIHR Clinician Scientist Fellowship (CS-2015-15-005), grants from Cicely Saunders International, during the conduct of the study. Prof Higginson reports grants from Medical Research Council [MR/V012908/1], grants from National Institute for Health Research (NIHR)Applied Research Collaboration South London, grants from Cicely Saunders International, during the conduct of the study. Prof Fraser reports grants from Medical Research Council [MR/V012908/1], grants from NIHR Career Development Fellowship (CDF-2018-11-ST2-002), during the conduct of the study; . Dr. Maddocks reports grants from Medical Research Council [MR/V012908/1], grants from National Institute for Health Research (NIHR)Applied Research Collaboration South London, grants from National Institute for Health Research (NIHR) Career Development Fellowship (CDF-2017-10-009), during the conduct of the study; . Ms Cripps reports grants from Medical Research Council [MR/V012908/1], grants from National Institute for Health Research (NIHR) Applied Research Collaboration, South London, grants from Cicely Saunders International, during the conduct of the study; . Prof Murtagh reports grants from Medical Research Council [MR/V012908/1], other from NIHR Senior Investigator, during the conduct of the study; .
Clinical Trial
ISRCTN16561225
Funding Statement
This research was supported by Medical Research Council grant number MR/V012908/1. Additional support was from the National Institute for Health Research (NIHR) Applied Research Collaboration South London hosted at King's College Hospital NHS Foundation Trust, and Cicely Saunders International (Registered Charity No. 1087195). IJH is a National Institute for Health Research (NIHR) Emeritus Senior Investigator and is supported by the NIHR Applied Research Collaboration (ARC) South London (SL) at King's College Hospital National Health Service Foundation Trust. IJH leads the Palliative and End of Life Care theme of the NIHR ARC SL and co-leads the national theme in this. MM is funded by a NIHR Career Development Fellowship (CDF-2017-10-009) and NIHR ARC SL. LF is funded by a NIHR Career Development Fellowship (CDF-2018-11-ST2-002). KS is funded by a NIHR Clinician Scientist Fellowship (CS-2015-15-005). RC is funded by Cicely Saunders International. FEM is a NIHR Senior Investigator. MBH is supported by the NIHR ARC SL. The views expressed in this article are those of the authors and not necessarily those of the NIHR, or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey received ethical (Institutional Review Board) approval from King's College London Research Ethics committee (LRS-19/20-18541).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Applications for use of the survey data can be made for up to 10 years, and will be considered on a case by case basis on receipt of a methodological sound proposal to achieve aims in line with the original protocol. The study protocol is available on request. All requests for data access should be addressed to the Chief Investigator via the details on the CovPall website (https://www.kcl.ac.uk/cicelysaunders/research/evaluating/covpall-study, and palliativecare{at}kcl.ac.uk) and will be reviewed by the Study Steering Group.
